SCHEMBL9594310

SCHEMBL9594310

Cc1ccc2nc3cc(C)c(C)cc3c(Nc3ccc(CO)cc3)c2c1

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 5/20 0.51
▸ ACHE P22303 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ RAD52 P43351 1/20 0.47
▸ TP53 P04637 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KMT2A Q03164 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ TOP2A P11388 1/20 0.44
▸ TOP2B Q02880 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9595308 0.93 KDM1A (0.56) KDM1AACHEPOLBGAARAD52
SCHEMBL9595398 0.92 KDM1A (0.51) KDM1AACHETOP2ATOP2B
SCHEMBL9593869 0.92 KDM1A (0.54) KDM1APOLBRAD52SMN1; SMN2KMT2A
SCHEMBL9595042 0.91 KDM1A (0.55) KDM1AACHETOP2ATOP2B
SCHEMBL9594919 0.88 MEN1 (0.46) KDM1AACHEPOLBGAARAD52
SCHEMBL9592705 0.88 MEN1 (0.46) KDM1AACHEPOLBGAARAD52
SCHEMBL9594083 0.87 KDM1A (0.67) KDM1ATOP2ATOP2B
SCHEMBL9593811 0.86 TOP2A (0.63) KDM1AACHETP53SMN1; SMN2KMT2A
SCHEMBL9595381 0.85 HDAC1 (0.54) KDM1APOLBGAARAD52KMT2A
SCHEMBL9594824 0.85 SLC2A1 (0.48) KDM1AACHEKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5229395-A Potential anticancer agents derived from acridine SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-07-20 — — US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO disclosed
Send feedback